Persistent Systems Q1 FY27 Results Analysis: Revenue Surges 29%, Margin Compresses 274 bps
Persistent Systems Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 4,303.23 Cr (+29.09% YoY) and PAT growth of +13.67% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 02, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 4,303.23 Cr (+29.09% YoY) |
| PAT (Q1) | Rs. 483.04 Cr (+13.67% YoY) |
| EBITDA margin | 16.19% (-216 bps YoY) |
| EPS (Q1) | Rs. 30.88 (+12.58% YoY) |
| Market cap | Rs. 87,535.48 Cr |
| CMP | Rs. 5,549.00 |
Quarter Snapshot
Persistent Systems delivered 29% YoY revenue growth, the fastest Q1 growth in recent history, with all three segments growing ~28-29%. However, EBITDA margin compressed 274 bps QoQ to 16.19% due to a surge in other expenses and finance costs tied to the Nagarro acquisition. The acquisition, if approved, will transform the company's scale, but near-term earnings will be pressured by deal-related costs.
Key Investment Insights
Key Positives
- Revenue grew 29.09% YoY to Rs.4,303.23 Cr, the fastest Q1 growth in recent history.
- All three operating segments (BFSI, Healthcare & Life Sciences, Software Hi-Tech) delivered ~28-29% YoY revenue growth.
- BFSI segment margin improved 125 bps YoY to 35.63%.
- Healthcare & Life Sciences revenue accelerated to +29.47% YoY from 7.4% in Q3 FY26.
- Subsidiary PAT contribution grew 40.6% YoY to Rs.81.02 Cr.
- Standalone EBITDA grew 14.63% YoY.
Risk Factors
- EBITDA margin compressed 274 bps QoQ to 16.19%, the lowest in five quarters.
- Other expenses surged 77.85% YoY and 39.70% QoQ to Rs.740.36 Cr, driven by Nagarro acquisition costs.
- Finance costs surged 56.05% QoQ and 70.79% YoY due to bridge financing for the Nagarro bid.
- PAT growth of 13.67% YoY lagged revenue growth of 29.09% YoY, indicating margin pressure.
- Subcontracting costs grew 39.11% YoY, faster than revenue, increasing reliance on external contractors.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.